151 related articles for article (PubMed ID: 27132870)
1. PD-1 inhibition in advanced Merkel-cell carcinoma.
Baker H
Lancet Oncol; 2016 Jun; 17(6):e225. PubMed ID: 27132870
[No Abstract] [Full Text] [Related]
2. Advances in the Treatment of Advanced Extracutaneous Melanomas and Nonmelanoma Skin Cancers.
Komatsubara KM; Jeter J; Carvajal RD; Margolin K; Schadendorf D; Hauschild A
Am Soc Clin Oncol Educ Book; 2017; 37():641-650. PubMed ID: 28561682
[TBL] [Abstract][Full Text] [Related]
3. Pre-treated anti-PD-1 refractory Merkel cell carcinoma successfully treated with the combination of PD-1/PD-L1 axis inhibitors and TVEC: a report of two cases.
Knackstedt R; Sussman TA; McCahon L; Song JM; Funchain P; Gastman B
Ann Oncol; 2019 Aug; 30(8):1399-1400. PubMed ID: 31250007
[No Abstract] [Full Text] [Related]
4. Non-Melanoma Skin Cancers: Biological and Clinical Features.
Cives M; Mannavola F; Lospalluti L; Sergi MC; Cazzato G; Filoni E; Cavallo F; Giudice G; Stucci LS; Porta C; Tucci M
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751327
[TBL] [Abstract][Full Text] [Related]
5. From genetic characterization to new potential therapeutic options: targeting Bcl-xL in Merkel carcinoma.
Kervarrec T
Br J Dermatol; 2023 Jul; 189(1):7. PubMed ID: 37146163
[No Abstract] [Full Text] [Related]
6. PD-1 (PDCD1) promoter methylation in Merkel cell carcinoma: prognostic relevance and relationship with clinico-pathological parameters.
Ricci C; Morandi L; Righi A; Gibertoni D; Maletta F; Ambrosi F; Agostinelli C; Uccella S; Asioli S; Sessa F; Pellilli M; Maragliano R; La Rosa S; Papotti MG; Asioli S
Mod Pathol; 2019 Sep; 32(9):1359-1372. PubMed ID: 30976104
[TBL] [Abstract][Full Text] [Related]
7. Anti-PD1 in Merkel cell carcinoma and cutaneous squamous cell carcinoma, description of five cases and recent data from the literature.
Sellah D; Saint-Jean M; Peuvrel L; Khammari A; Quéreux G; Dréno B
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):e159-e161. PubMed ID: 30451326
[No Abstract] [Full Text] [Related]
8. Antitumor and Anti-Hepatitis C Viral Response After Administration of the Anti-Programmed Death 1 Antibody Pembrolizumab.
Jang S; Venna S
J Oncol Pract; 2017 Jul; 13(7):462-464. PubMed ID: 28562196
[No Abstract] [Full Text] [Related]
9. Pembrolizumab-associated mucous membrane pemphigoid in a patient with Merkel cell carcinoma.
Haug V; Behle V; Benoit S; Kneitz H; Schilling B; Goebeler M; Gesierich A
Br J Dermatol; 2018 Oct; 179(4):993-994. PubMed ID: 29758087
[No Abstract] [Full Text] [Related]
10. Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?
Dasanu CA; Del Rosario M; Codreanu I; Hyams DM; Plaxe SC
J Oncol Pharm Pract; 2019 Jan; 25(1):214-216. PubMed ID: 29933728
[TBL] [Abstract][Full Text] [Related]
11. Merkel cell carcinoma in a child.
Köksal Y; Toy H; Talim B; Unal E; Akçören Z; Cengiz M
J Pediatr Hematol Oncol; 2009 May; 31(5):359-61. PubMed ID: 19415020
[TBL] [Abstract][Full Text] [Related]
12. Divergent response to PD-L1 inhibition in advanced Merkel cell carcinoma and cutaneous squamous cell carcinoma.
Salzmann M; Löser C; Hassel JC
J Dtsch Dermatol Ges; 2023 Jul; 21(7):803-805. PubMed ID: 37066606
[No Abstract] [Full Text] [Related]
13. Case 19-2008: Merkel-cell carcinoma.
Lemos BD; Yu SS; Nghiem P
N Engl J Med; 2008 Oct; 359(15):1629-30; author reply 1630-1. PubMed ID: 18843131
[No Abstract] [Full Text] [Related]
14. PD-1 blockade: a therapeutic option for treatment of metastatic Merkel cell carcinoma.
Winkler JK; Bender C; Kratochwil C; Enk A; Hassel JC
Br J Dermatol; 2017 Jan; 176(1):216-219. PubMed ID: 27038231
[TBL] [Abstract][Full Text] [Related]
15. Merkel cell carcinoma showing regression after biopsy: Evaluation of programmed cell death 1-positive cells.
Fujimoto N; Nakanishi G; Kabuto M; Nakano T; Eto H; Nakajima H; Sano S; Tanaka T
J Dermatol; 2015 May; 42(5):496-9. PubMed ID: 25708589
[TBL] [Abstract][Full Text] [Related]
16. Merkel cell carcinoma.
Goessling W; McKee PH; Mayer RJ
J Clin Oncol; 2002 Jan; 20(2):588-98. PubMed ID: 11786590
[No Abstract] [Full Text] [Related]
17. In-field and abscopal response after short-course radiation therapy in patients with metastatic Merkel cell carcinoma progressing on PD-1 checkpoint blockade: a case series.
Xu MJ; Wu S; Daud AI; Yu SS; Yom SS
J Immunother Cancer; 2018 May; 6(1):43. PubMed ID: 29848371
[TBL] [Abstract][Full Text] [Related]
18. Use of interferon-alpha in two patients with Merkel cell carcinoma positive for Merkel cell polyomavirus.
Biver-Dalle C; Nguyen T; Touzé A; Saccomani C; Penz S; Cunat-Peultier S; Riou-Gotta MO; Humbert P; Coursaget P; Aubin F
Acta Oncol; 2011 Apr; 50(3):479-80. PubMed ID: 20825355
[No Abstract] [Full Text] [Related]
19. Overview of Merkel cell carcinoma and recent advances in research.
Smith K; Skelton H
Int J Dermatol; 2003 Sep; 42(9):749-51. PubMed ID: 12956696
[No Abstract] [Full Text] [Related]
20. Treatment of a multicentric Merkel cell carcinoma using imatinib.
Peuvrel L; Quereux G; Brocard A; Renaut JJ; Dréno B
Eur J Dermatol; 2011; 21(6):1009-10. PubMed ID: 21926041
[No Abstract] [Full Text] [Related]
[Next] [New Search]
